Equities research analysts forecast that MKS Instruments, Inc. (NASDAQ:MKSI) will report sales of $570.45 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for MKS Instruments’ earnings, with the lowest sales estimate coming in at $570.00 million and the highest estimate coming in at $570.90 million. MKS Instruments reported sales of $480.76 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 18.7%. The firm is scheduled to announce its next earnings results on Tuesday, July 24th.
According to Zacks, analysts expect that MKS Instruments will report full-year sales of $2.18 billion for the current fiscal year, with estimates ranging from $2.16 billion to $2.21 billion. For the next financial year, analysts anticipate that the company will report sales of $2.37 billion per share, with estimates ranging from $2.25 billion to $2.52 billion. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for MKS Instruments.
MKS Instruments (NASDAQ:MKSI) last released its quarterly earnings results on Tuesday, April 24th. The scientific and technical instruments company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $2.00 by $0.07. The firm had revenue of $554.00 million for the quarter, compared to analysts’ expectations of $530.68 million. MKS Instruments had a net margin of 18.65% and a return on equity of 23.94%. The business’s quarterly revenue was up 26.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.27 earnings per share.
A number of research analysts recently commented on MKSI shares. BidaskClub cut MKS Instruments from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 12th. Zacks Investment Research cut MKS Instruments from a “buy” rating to a “hold” rating in a research note on Wednesday, April 4th. Benchmark started coverage on MKS Instruments in a research note on Thursday, May 31st. They issued a “buy” rating and a $140.00 target price on the stock. ValuEngine cut MKS Instruments from a “buy” rating to a “hold” rating in a research note on Thursday, April 19th. Finally, Deutsche Bank increased their target price on MKS Instruments to $140.00 and gave the company a “buy” rating in a research note on Thursday, March 22nd. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. MKS Instruments has a consensus rating of “Buy” and a consensus price target of $130.29.
MKS Instruments traded down $1.65, reaching $94.85, during trading on Thursday, according to MarketBeat Ratings. The stock had a trading volume of 352,300 shares, compared to its average volume of 648,751. The stock has a market cap of $5.23 billion, a PE ratio of 16.19, a P/E/G ratio of 1.17 and a beta of 0.95. The company has a quick ratio of 3.24, a current ratio of 4.49 and a debt-to-equity ratio of 0.20. MKS Instruments has a one year low of $66.80 and a one year high of $128.28.
The firm also recently declared a quarterly dividend, which was paid on Friday, June 8th. Shareholders of record on Monday, May 28th were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 0.84%. This is a positive change from MKS Instruments’s previous quarterly dividend of $0.18. The ex-dividend date of this dividend was Thursday, May 24th. MKS Instruments’s dividend payout ratio is presently 13.42%.
In other MKS Instruments news, CEO Gerard G. Colella sold 10,000 shares of the company’s stock in a transaction dated Tuesday, May 1st. The shares were sold at an average price of $101.92, for a total transaction of $1,019,200.00. Following the completion of the sale, the chief executive officer now directly owns 42,294 shares in the company, valued at $4,310,604.48. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Richard S. Chute sold 1,988 shares of the company’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $110.75, for a total transaction of $220,171.00. Following the sale, the director now owns 10,103 shares of the company’s stock, valued at $1,118,907.25. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 16,512 shares of company stock valued at $1,739,002. Company insiders own 1.67% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Optimum Investment Advisors purchased a new stake in shares of MKS Instruments during the first quarter worth about $202,000. CIBC Asset Management Inc purchased a new stake in shares of MKS Instruments during the first quarter worth about $223,000. Cigna Investments Inc. New purchased a new stake in shares of MKS Instruments during the first quarter worth about $235,000. Lido Advisors LLC purchased a new stake in shares of MKS Instruments during the first quarter worth about $241,000. Finally, Cetera Advisor Networks LLC purchased a new stake in shares of MKS Instruments during the first quarter worth about $254,000. Institutional investors and hedge funds own 93.40% of the company’s stock.
About MKS Instruments
MKS Instruments, Inc provides instruments, subsystems, and process control solutions that measure, control, power, deliver, monitor, and analyze critical parameters of manufacturing processes worldwide. The company operates through two segments, Vacuum & Analysis and Light & Motion. The Vacuum & Analysis segment provides analytical and control solutions products, including gas analyzers, automation control products, I/O modules, automation software, and precision machined components and electromechanical assemblies; and materials delivery solutions products comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems to provide customers with precise control capabilities that are optimized for a given application.
Get a free copy of the Zacks research report on MKS Instruments (MKSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.